Brand: Rogers
The Rogers Panthera T75 is a series 1 categorized CRISPR-Cas9 genome editing tool developed by the biotech company, Rogers Communications Science, as part of their Panthera portfolio. This technology allows for precise and targeted gene editing in various organisms, including mammalian cells, embryos, and bacterial cultures. The T75 variant is specifically designed with improved efficiency and reduced off-target effects compared to other CRISPR-Cas9 systems. Its use has the potential to unlock new therapeutic approaches and advance research in diverse fields such as medicine, agriculture, and biotechnology.